In vivo, due to the harsh microenvironment of kidney cancers, it is highly likely that cancer cells possess an elevated ER stress level, thus an escalated dependence on FADS1 function, as indicated by the aforementioned increased FADS1 expression in more advanced stages of RCC. This evidence concerns the gene FADS1 and kidney cancer.